1. Home
  2. CHCT vs BWAY Comparison

CHCT vs BWAY Comparison

Compare CHCT & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Healthcare Trust Incorporated

CHCT

Community Healthcare Trust Incorporated

HOLD

Current Price

$16.23

Market Cap

410.6M

Sector

Real Estate

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$18.93

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHCT
BWAY
Founded
2014
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
410.6M
337.9M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
CHCT
BWAY
Price
$16.23
$18.93
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$18.00
$23.50
AVG Volume (30 Days)
216.2K
72.6K
Earning Date
02-17-2026
11-11-2025
Dividend Yield
11.91%
N/A
EPS Growth
N/A
213.09
EPS
N/A
0.13
Revenue
$119,547,000.00
$49,094,000.00
Revenue This Year
$6.97
$330.76
Revenue Next Year
$5.98
$22.24
P/E Ratio
N/A
$61.62
Revenue Growth
3.40
27.08
52 Week Low
$13.23
$7.84
52 Week High
$20.87
$19.80

Technical Indicators

Market Signals
Indicator
CHCT
BWAY
Relative Strength Index (RSI) 63.40 63.07
Support Level $15.57 $18.31
Resistance Level $16.28 $19.80
Average True Range (ATR) 0.31 0.82
MACD 0.03 0.21
Stochastic Oscillator 97.10 80.68

Price Performance

Historical Comparison
CHCT
BWAY

About CHCT Community Healthcare Trust Incorporated

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: